100.00% -28.69

Damora Therapeutics Inc (GLTO)

Overview News Price History Option Chain Financials Discussions Forecast

Damora Therapeutics Inc Stock (GLTO) Forecast

The Damora Therapeutics Inc (GLTO) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $4.9357, representing a + increase from the current price of $0.00. The highest analyst price target is $4.8886, and the lowest is $4.9828.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month GLTO Price Target

Average 3.3054 (+ Upside)

Is Damora Therapeutics Inc (GLTO) A Buy Now?

Oscillators

Name	Value	Action
RSI(14)	18.62	Buy
STOCH(9,6)	17.18	Buy
STOCHRSI(14)	8.8872	Buy
MACD(12,26)	-1.5324	Sell
ADX(14)	26.61	Sell
William %R	-100.00	Buy
CCI(14)	-445.45	Sell

Buy: 4 Sell: 3 Neutral: 0

Summary: Buy

Moving Averages

Period	Simple	Exponential
MA10	26.54 Sell	23.82 Sell
MA20	27.51 Sell	25.89 Sell
MA50	25.83 Sell	25.40 Sell
MA100	22.00 Sell	21.84 Sell
MA200	12.98 Sell	16.17 Sell

Buy: 0 Sell: 10 Neutral: 0

Summary: Sell

According to our latest analysis, GLTO could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 13 signaling Sell signals and 0 Neutral signals. This might not be a good time to consider opening new positions on GLTO, as trading bearish markets can be challenging and may result in losses.

RSI (Relative Strength Index): The RSI(14) value of 18.62 indicates that GLTO is oversold. This indicates that GLTO price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
STOCH (Stochastic Oscillator): The STOCH value of 17.18 indicates that GLTO is oversold. This indicates that GLTO price is at or near the lowest level over a specified lookback period.
STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 8.8872 indicates that GLTO is oversold. This suggests that GLTO price is at or near the lowest level relative to its recent price history.
ADX (Average Directional Index): The ADX value of The ADX value of 26.61 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -445.45 indicates that GLTO is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.

Long-term GLTO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Damora Therapeutics Inc financial reports and earnings history, Damora Therapeutics Inc (GLTO) stock could reach $15.76 by 2030, $4.7025 by 2040 and $54.38 by 2050. See the projected annual prices until 2050 of the Damora Therapeutics Inc stock below:

Damora Therapeutics Inc (GLTO) is expected to reach an average price of $12.08 in 2035, with a high prediction of $12.85 and a low estimate of $12.63. This indicates an $ rise from the last recorded price of $0.00.
Damora Therapeutics Inc (GLTO) stock is projected to chart a bullish course in 2040, with an average price target of $3.9622, representing an $ surge from its current level. The forecast ranges from a conservative $4.0019 to a sky-high $4.7025.
Our analysts predict Damora Therapeutics Inc (GLTO) to jump by 2045, soaring from $64.38 to an average price of $64.27, potentially reaching $65.31. While $64.38 is the low estimate, the potential upside is significant.
Damora Therapeutics Inc (GLTO) stock is expected to climb by 2050, reaching an average of $53.14, a $ jump from its current level. However, a wide range of estimates exists, with high and low targets of $54.38 and $53.22, respectively, highlighting the market's uncertainty.

Damora Therapeutics Inc Stock (GLTO) Year by Year Forecast

Damora Therapeutics Inc Stock (GLTO) Price Forecast for 2026

The predicted value for Damora Therapeutics Inc (GLTO) in 2026 is set at an average of $5.1415. Estimates vary from a peak of $7.1249 to a trough of $3.1582, indicating an + surge from the present price of $0.00.

Month	Average	Low	High	Change from today's price
June, 2026	$5.2015	$4.9828	$4.8886	+
July, 2026	$4.746	$4.946	$5.0002	+
August, 2026	$5.0376	$4.8489	$4.8176	+
September, 2026	$4.9921	$4.8592	$4.7621	+
October, 2026	$4.0137	$4.102	$4.835	+
November, 2026	$2.9653	$3.2153	$3.5438	+
December, 2026	$3.5798	$3.1582	$3.0998	+

Damora Therapeutics Inc Stock (GLTO) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Damora Therapeutics Inc (GLTO) is $1.9296, with a high forecast of $3.0557 and a low forecast of $0.8035. This indicates an + increase from the last price of $0.00.

Month	Average	Low	High	Change from today's price
January, 2027	$3.1114	$3.1114	$3.0557	+
February, 2027	$2.5984	$2.9872	$2.9643	+
March, 2027	$2.2174	$2.3316	$2.4959	+
April, 2027	$1.619	$1.877	$1.8703	+
May, 2027	$0.8506	$1.6106	$1.4177	+
June, 2027	$2.95	$0.8035	$2.8711	+
July, 2027	$2.674	$2.7117	$2.819	+
August, 2027	$2.3808	$2.3885	$2.5939	+
September, 2027	$2.0828	$2.1275	$2.2592	+
October, 2027	$1.7944	$1.7944	$1.9577	+
November, 2027	$1.406	$1.5249	$1.6573	+
December, 2027	$1.1784	$1.1805	$1.2589	+

Damora Therapeutics Inc Stock (GLTO) Price Forecast for 2028

In 2028, Damora Therapeutics Inc (GLTO) is projected to reach an average price of $10.00, with a high projection of $19.94 and a low estimate of $0.0568. This indicates an + rise from the last price of $0.00.

Month	Average	Low	High	Change from today's price
January, 2028	$0.8584	$0.882	$1.0559	+
February, 2028	$0.4357	$0.5266	$0.6731	+
March, 2028	$0.2366	$0.281	$0.3665	+
April, 2028	$13.86	$0.0568	$13.08	+
May, 2028	$14.15	$12.93	$12.44	+
June, 2028	$15.36	$14.48	$13.73	+
July, 2028	$14.95	$15.04	$14.21	+
August, 2028	$17.41	$15.13	$15.42	+
September, 2028	$20.05	$17.45	$19.51	+
October, 2028	$19.59	$20.00	$19.76	+
November, 2028	$19.61	$19.83	$19.94	+
December, 2028	$19.13	$19.57	$19.08	+

Damora Therapeutics Inc Stock (GLTO) Price Forecast for 2029

The 2029 price forecast for Damora Therapeutics Inc Stock (GLTO) is $17.22 on average, with a high prediction of $19.08 and a low estimate of $15.35. This represents an + increase from the previous price of $0.00.

Month	Average	Low	High	Change from today's price
January, 2029	$19.31	$19.19	$19.08	+
February, 2029	$19.08	$19.23	$19.08	+
March, 2029	$18.24	$18.37	$18.47	+
April, 2029	$18.58	$18.49	$18.51	+
May, 2029	$18.09	$18.15	$18.39	+
June, 2029	$18.07	$17.98	$17.93	+
July, 2029	$17.07	$17.67	$17.87	+
August, 2029	$17.42	$17.22	$17.34	+
September, 2029	$17.27	$17.18	$17.05	+
October, 2029	$16.26	$16.69	$16.95	+
November, 2029	$15.28	$15.88	$15.86	+
December, 2029	$15.89	$15.35	$15.58	+

Damora Therapeutics Inc Stock (GLTO) Price Forecast for 2030

Damora Therapeutics Inc Stock (GLTO) is expected to reach an average price of $12.22 in 2030, with a high forecast of $15.76 and a low forecast of $8.6838. This signifies an + surge from the last price of $0.00.

Month	Average	Low	High	Change from today's price
January, 2030	$14.77	$15.46	$15.76	+
February, 2030	$14.47	$14.50	$14.40	+
March, 2030	$13.99	$14.07	$14.22	+
April, 2030	$13.12	$13.21	$13.83	+
May, 2030	$12.14	$12.25	$12.45	+
June, 2030	$12.01	$12.11	$12.05	+
July, 2030	$11.50	$11.54	$11.89	+
August, 2030	$11.20	$11.27	$11.31	+
September, 2030	$11.02	$11.08	$11.03	+
October, 2030	$9.199	$9.419	$10.25	+
November, 2030	$8.7322	$8.7064	$8.5648	+
December, 2030	$8.5053	$8.6838	$8.3881	+